The Valley Desk

NCT07735637 · Interventional trial

A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).

Overall registry status Recruiting

Phase 3

Conditions Newly Diagnosed Multiple Myeloma (NDMM)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov